Literature DB >> 11746986

Identification and functional characterization of the promoter region of the human MSH6 gene.

Marta Szadkowski1, Josef Jiricny.   

Abstract

Postreplicative mismatch repair (MMR) corrects polymerase errors arising during DNA replication. Consistent with this role, the Saccharomyces cerevisiae MMR genes MSH2, MSH6, and PMS1 were reported to be transcriptionally upregulated during late G(1) phase of the cell cycle. Surprisingly, despite the high degree of conservation of the MMR system in evolution, the human MMR genes studied to date, MSH2, MLH1, and PMS2, appear to be transcribed from classical housekeeping promoters, and the amounts of the polypeptides encoded by them fluctuate little during the cell cycle. Only the amounts of the 160-kDa MSH6 protein were reported to vary, both during development and following stimulation of cell growth. Moreover, transcription of this gene was found to be downregulated by CpG methylation of the promoter region in a subset of clones treated with alkylating agents. In an attempt to understand the molecular basis underlying these phenomena, we isolated the 5' region of the MSH6 gene and subjected it to functional analysis. We now show that the MSH6 gene is also transcribed from a classical housekeeping gene promoter. Despite housing putative binding sites for the transcription factors AP1, NF-kappaB, and MTF-1, the MSH6 promoter failed to respond to ionizing radiation or heavy metals. Interestingly, MSH6 transcription was upregulated during late G(1) phase, even though the levels of the protein remained essentially constant during the cell cycle.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11746986     DOI: 10.1002/gcc.1211

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  6 in total

1.  Regulation of the human MSH6 gene by the Sp1 transcription factor and alteration of promoter activity and expression by polymorphisms.

Authors:  Isabella Gazzoli; Richard D Kolodner
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

2.  Mismatch repair deficiency does not mediate clinical resistance to temozolomide in malignant glioma.

Authors:  Jill A Maxwell; Stewart P Johnson; Roger E McLendon; David W Lister; Krystle S Horne; Ahmed Rasheed; Jennifer A Quinn; Francis Ali-Osman; Allan H Friedman; Paul L Modrich; Darell D Bigner; Henry S Friedman
Journal:  Clin Cancer Res       Date:  2008-08-01       Impact factor: 12.531

3.  Interplay between mismatch repair and chromatin assembly.

Authors:  Barbara Schöpf; Stephanie Bregenhorn; Jean-Pierre Quivy; Farid A Kadyrov; Genevieve Almouzni; Josef Jiricny
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-09       Impact factor: 11.205

4.  Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers.

Authors:  Paul J Goodfellow; Barbara M Buttin; Thomas J Herzog; Janet S Rader; Randall K Gibb; Elizabeth Swisher; Katherine Look; Ken C Walls; Ming-Yu Fan; David G Mutch
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-05       Impact factor: 11.205

5.  Association of MSH6 mutation with glioma susceptibility, drug resistance and progression.

Authors:  Chaoran Xie; Hansong Sheng; Nu Zhang; Shiting Li; Xiangyu Wei; Xuesheng Zheng
Journal:  Mol Clin Oncol       Date:  2016-05-20

6.  Cell cycle regulation as a mechanism for functional separation of the apparently redundant uracil DNA glycosylases TDG and UNG2.

Authors:  Ulrike Hardeland; Christophe Kunz; Frauke Focke; Marta Szadkowski; Primo Schär
Journal:  Nucleic Acids Res       Date:  2007-05-25       Impact factor: 16.971

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.